{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:10:14Z","timestamp":1787793014894,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA093237"],"award-info":[{"award-number":["R01CA093237"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,4,8]]},"DOI":"10.1038\/s41388-022-02243-8","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T11:02:48Z","timestamp":1645700568000},"page":"2187-2195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-9035","authenticated-orcid":false,"given":"Akihiro","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Phillips-Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8158-1326","authenticated-orcid":false,"given":"Vincenzo","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-5049","authenticated-orcid":false,"given":"J. Alan","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"2243_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","volume":"79","author":"CJ Sherr","year":"1994","unstructured":"Sherr CJ. G1 phase progression: cycling on cue. Cell.1994;79:551\u20135.","journal-title":"Cell"},{"key":"2243_CR2","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","volume":"274","author":"CJ Sherr","year":"1996","unstructured":"Sherr CJ. Cancer cell cycles. Science.1996;274:1672\u20137.","journal-title":"Science"},{"key":"2243_CR3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/0092-8674(93)90636-5","volume":"73","author":"CJ Sherr","year":"1993","unstructured":"Sherr CJ. Mammalian G1 cyclins. Cell.1993;73:1059\u201365.","journal-title":"Cell"},{"key":"2243_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12:9\u201318.","journal-title":"Cell Res"},{"key":"2243_CR5","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1038\/sj.onc.1210414","volume":"26","author":"S Meloche","year":"2007","unstructured":"Meloche S, Pouyss\u00e9gur J. The ERK1\/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene.2007;26:3227\u201339.","journal-title":"Oncogene"},{"key":"2243_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2006.09.007","volume":"24","author":"DI Lin","year":"2006","unstructured":"Lin DI, Barbash O, Kumar KG, Weber JD, Harper JW, Klein-Szanto AJ, et al. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. Mol Cell. 2006;24:355\u201366.","journal-title":"Mol Cell"},{"key":"2243_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1101\/gad.11.8.957","volume":"11","author":"JA Diehl","year":"1997","unstructured":"Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 1997;11:957\u201372.","journal-title":"Genes Dev"},{"key":"2243_CR8","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","volume":"12","author":"JA Diehl","year":"1998","unstructured":"Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998;12:3499\u2013511.","journal-title":"Genes Dev"},{"key":"2243_CR9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/sj.onc.1209147","volume":"25","author":"AB Gladden","year":"2006","unstructured":"Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene.2006;25:998\u20131007.","journal-title":"Oncogene"},{"key":"2243_CR10","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1101\/gad.1586007","volume":"21","author":"P Aggarwal","year":"2007","unstructured":"Aggarwal P, Lessie MD, Lin DI, Pontano L, Gladden AB, Nuskey B, et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev. 2007;21:2908\u201322.","journal-title":"Genes Dev"},{"key":"2243_CR11","doi-asserted-by":"publisher","first-page":"7245","DOI":"10.1128\/MCB.01085-08","volume":"28","author":"LL Pontano","year":"2008","unstructured":"Pontano LL, Aggarwal P, Barbash O, Brown EJ, Bassing CH, Diehl JA. Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability. Mol Cell Biol. 2008;28:7245\u201358.","journal-title":"Mol Cell Biol"},{"key":"2243_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ccr.2010.08.012","volume":"18","author":"P Aggarwal","year":"2010","unstructured":"Aggarwal P, Vaites LP, Kim JK, Mellert H, Gurung B, Nakagawa H, et al. Nuclear cyclin D1\/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell. 2010;18:329\u201340.","journal-title":"Cancer Cell"},{"key":"2243_CR13","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.CD-14-0625","volume":"5","author":"Y Li","year":"2015","unstructured":"Li Y, Chitnis N, Nakagawa H, Kita Y, Natsugoe S, Yang Y, et al. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Disco. 2015;5:288\u2013303.","journal-title":"Cancer Disco"},{"key":"2243_CR14","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.90.20.9571","volume":"90","author":"K Ando","year":"1993","unstructured":"Ando K, Ajchenbaum-Cymbalista F, Griffin JD. Regulation of G1\/S transition by cyclins D2 and D3 in hematopoietic cells. Proc Natl Acad Sci. 1993;90:9571\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"2243_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1101\/gad.262568.115","volume":"29","author":"E Caserta","year":"2015","unstructured":"Caserta E, Egriboz O, Wang H, Martin C, Koivisto C, Pec\u00f3t T, et al. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev. 2015;29:1707\u201320.","journal-title":"Genes Dev"},{"key":"2243_CR16","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","volume":"68","author":"T Daikoku","year":"2008","unstructured":"Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, et al. Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res. 2008;68:5619\u201327.","journal-title":"Cancer Res"},{"key":"2243_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1242\/dmm.004440","volume":"3","author":"CM Contreras","year":"2010","unstructured":"Contreras CM, Akbay EA, Gallardo TD, Haynie JM, Sharma S, Tagao O, et al. Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy. Dis Models Mechanisms. 2010;3:181\u201393.","journal-title":"Dis Models Mechanisms"},{"key":"2243_CR18","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.","journal-title":"Signal Transduct Target Ther"},{"key":"2243_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.","journal-title":"Mol Cancer"},{"key":"2243_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11686","volume":"7","author":"HJ Kwon","year":"2016","unstructured":"Kwon HJ, Choi GE, Ryu S, Kwon SJ, Kim SC, Booth C, et al. Stepwise phosphorylation of p65 promotes NF-\u03baB activation and NK cell responses during target cell recognition. Nat Commun. 2016;7:11686.","journal-title":"Nat Commun"},{"key":"2243_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fendo.2019.00106","volume":"10","author":"L Masclef","year":"2019","unstructured":"Masclef L, Dehennaut V, Mortuaire M, Schulz C, Leturcq M, Lefebvre T, et al. Cyclin D1 stability is partly controlled by O-GlcNAcylation. Front Endocrinol (Lausanne). 2019;10:106.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2243_CR22","doi-asserted-by":"publisher","first-page":"13516","DOI":"10.1073\/pnas.1311784110","volume":"110","author":"H Wei","year":"2013","unstructured":"Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB, et al. PRMT5 dimethylates R30 of the p65 subunit to activate NF-\u03baB. Proc Natl Acad Sci USA. 2013;110:13516\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2243_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008;22:1490\u2013500.","journal-title":"Genes Dev"},{"key":"2243_CR24","doi-asserted-by":"publisher","first-page":"27740","DOI":"10.1074\/jbc.M102559200","volume":"276","author":"JA Gustin","year":"2001","unstructured":"Gustin JA, Maehama T, Dixon JE, Donner DB. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. J Biol Chem. 2001;276:27740\u20134.","journal-title":"J Biol Chem"},{"key":"2243_CR25","doi-asserted-by":"publisher","first-page":"e12858","DOI":"10.1111\/acel.12858","volume":"18","author":"Y Tian","year":"2019","unstructured":"Tian Y, Li H, Qiu T, Dai J, Zhang Y, Chen J, et al. Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-\u03baB activation. Aging Cell. 2019;18:e12858.","journal-title":"Aging Cell"},{"key":"2243_CR26","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1182\/blood.V104.11.4438.4438","volume":"104","author":"L Gu","year":"2004","unstructured":"Gu L, Zhu N, Findley HW, Zhou M. Loss of PTEN expression induces NF-kB Via PI3K\/Akt pathway involving resistance to chemotherapy in acute lymphoblastic leukemia cell lines. Blood.2004;104:4438.","journal-title":"Blood"},{"key":"2243_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0092-8674(92)90360-O","volume":"71","author":"H Matsushime","year":"1992","unstructured":"Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3\/cdk4) for mammalian D type G1 cyclins. Cell.1992;71:323\u201334.","journal-title":"Cell"},{"key":"2243_CR28","first-page":"2066","volume":"14","author":"H Matsushime","year":"1994","unstructured":"Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 1994;14:2066\u201376.","journal-title":"Mol Cell Biol"},{"key":"2243_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinforma (Oxf, Engl). 2013;29:15\u201321.","journal-title":"Bioinforma (Oxf, Engl)"},{"key":"2243_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511\u20135.","journal-title":"Nat Biotechnol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02243-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T13:07:50Z","timestamp":1649423270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02243-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":30,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,4,8]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02243-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}